Highlights Quantum Genomics

Equities

ALQGC

FR0011648971

Market Closed - Euronext Paris Other stock markets 11:29:46 2024-04-30 am EDT			5-day change	1st Jan Change
0.1274 ^EUR	+6.34%		+14.57%	+20.19%

Mar. 13	Quantum Genomics Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Quantum Genomics Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Quantum Genomics Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 12	CI
Quantum Genomics Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	23-10-24	CI
Quantum Genomics Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-26	CI
Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, Fresh and Is Redirecting to New Developments	22-10-28	CI
Quantum Genomics Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2022	22-10-05	CI
Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH	22-05-09	CI
Quantum Genomics Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-28	CI
Quantum Genomics Announces Publication of a New Scientific Article Featuring QGC606	22-03-31	CI
Quantum Genomics Secures New Patents For Potential Heart Drug QGC606	22-03-29	MT
Quantum Genomics Announces Granting of New Patents Protecting QGC606	22-03-28	CI
Quantum Genomics Société Anonyme Signs an Exclusive License and Production Agreement with Julphar	21-12-06	CI
Quantum Genomics Signs an Exclusive License Agreement with Teva Israel Ltd	21-11-25	CI
Quantum Genomics Société Anonyme and its Partners Reach a New Stage of Development in Asia	21-10-07	CI
Quantum Genomics Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2021	21-10-06	CI
Global markets live: Nvidia, Microsoft, Dell, Apple, Uber...	21-08-27
Quantum Genomics Presents Results from Phase IIb QUORUM Study of Firibastat	21-08-27	CI
Global markets live: Microsoft, Deliveroo, Didi, Biogen, Tesla...	21-07-08
Quantum Genomics Enrolls First Patient in Its Pivotal Phase III REFRESH Trial of Firibastat in Difficult-to-Treat and Resistant Hypertension with Once-a-Day Formulation of Firibastat	21-07-08	CI
Global markets live: WM Morrison, IBM, Didi...	21-07-05
Quantum Genomics Will Present Top-Line Results from its Quorum Study of Firibastat in Heart Failure Post Myocardial Infarction	21-04-21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Quantum Genomics

Equities

ALQGC

FR0011648971

Highlights

Filters